News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

105,352 Results

Type

Article (4226)
Company Profile (22)
Press Release (101104)

Section

Business (31937)
Career Advice (107)
Deals (5247)
Drug Delivery (4)
Drug Development (5392)
Employer Resources (11)
FDA (3187)
Job Trends (2073)
News (46871)
Policy (3869)

Tag

Date

Today (18)
Last 7 days (97)
Last 30 days (387)
Last 365 days (5445)
2024 (4016)
2023 (6127)
2022 (10208)
2021 (9617)
2020 (8992)
2019 (6146)
2018 (4851)
2017 (5399)
2016 (5389)
2015 (6109)
2014 (4629)
2013 (4126)
2012 (4434)
2011 (4628)
2010 (4078)

Filters

Type

Article (4226)
Company Profile (22)
Press Release (101104)

Section

Business (31937)
Career Advice (107)
Deals (5247)
Drug Delivery (4)
Drug Development (5392)
Employer Resources (11)
FDA (3187)
Job Trends (2073)
News (46871)
Policy (3869)

Tag

Date

Today (18)
Last 7 days (97)
Last 30 days (387)
Last 365 days (5445)
2024 (4016)
2023 (6127)
2022 (10208)
2021 (9617)
2020 (8992)
2019 (6146)
2018 (4851)
2017 (5399)
2016 (5389)
2015 (6109)
2014 (4629)
2013 (4126)
2012 (4434)
2011 (4628)
2010 (4078)

105,352 Results for "dxterity diagnostics".

Sort By

Policy

Radical Imaging Announces FDA Clearance for FlexView Diagnostic, its SaaS Image Viewer for Diagnostic Use.

Radical Imaging, a trailblazer in medical imaging viewer solutions, proudly announces that FlexView Diagnostic, its SaaS web DICOM viewer product, received FDA clearance for diagnostic use.

June 24, 2024
·
2 min read
Pharm Country

Quest Diagnostics Releases 2023 Corporate Responsibility Report

Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.

June 27, 2024
·
3 min read
Deals

Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics’ Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis

Quest Diagnostics, a leader in diagnostic information services, announced that it has completed its previously announced acquisition of PathAI Diagnostics from PathAI, with the goal to accelerate the adoption of AI and digital pathology to improve the diagnosis of cancer and other diseases.

June 11, 2024
·
3 min read
Biotech Beach

DxTerity Receives New York Authorization for Type 1 Interferon (IFN-1) Gene Signature Testing for Systemic Lupus Erythematosus Patients

The DxTerity IFN-1 gene signature test is for patients with Systemic Lupus Erythematosus (SLE or lupus), a chronic autoimmune disease affecting up to 1 million patients in the US.

September 16, 2022
·
2 min read
Business

Mosaic Diagnostics Appoints Healthcare Industry Veteran Rob Rebak as CEO

Mosaic Diagnostics is pleased to announce the appointment of Rob Rebak as Chief Executive Officer.

June 27, 2024
·
3 min read
Business

Progentec Diagnostics Announces Appointment of Immunology Expert Dr. Bernard Rubin

Progentec Diagnostics, a leader in diagnostic and digital technologies for management of autoimmune diseases, announced that Bernard R. Rubin, DO, MPH, seasoned rheumatology and immunology expert, has joined Progentec’s leadership team as Chief Medical Officer.

June 17, 2024
·
2 min read
BioCapital

Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics

Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), a leading global life sciences and diagnostics innovator, today announced that Julie Sawyer Montgomery will succeed Joakim Weidemanis as Executive Vice President, Diagnostics effective as of July 1, 2024.

June 19, 2024
·
6 min read
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.

June 18, 2024
·
1 min read
Business

Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024

Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2024 financial results on Tuesday, July 23, 2024, before the market opens.

June 19, 2024
·
1 min read
Press Releases

Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation

August 26, 2024
·
7 min read

1 of 10,536

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin